In conclusion, our research findings indicate that SMS alleviates lipid accumulation, oxidative stress, and inflammation in NAFLD by inhibiting the ROS/TXNIP/NLRP3-mediated pyroptosis pathway (Figure 11). This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatotic liver disease.